Cargo Therapeutics (CRGX)

$18.85

-0.36

(-1.87%)

Market is closed - opens 7 PM, 09 Sep 2024

Performance

  • $18.48
    $19.44
    $18.85
    downward going graph

    1.96%

    Downside

    Day's Volatility :4.94%

    Upside

    3.03%

    downward going graph
  • $13.14
    $33.92
    $18.85
    downward going graph

    30.29%

    Downside

    52 Weeks Volatility :61.26%

    Upside

    44.43%

    downward going graph

Returns

PeriodCargo TherapeuticsIndex (Russel 2000)
3 Months
4.96%
0.0%
6 Months
-41.51%
0.0%
1 Year
29.73%
0.0%
3 Years
29.73%
-22.3%

Highlights

Market Capitalization
941.1M
Wall Street Target Price
25.5
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
0.0%
Return On Equity TTM
0.0%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
EBITDA
-71.6M
Diluted Eps TTM
0.0
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-22.47
EPS Estimate Next Year
-5.83
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    90%Buy
    10%Hold
    0
    0%Sell
Based on 10 Wall street analysts offering stock ratings for Cargo Therapeutics(by analysts ranked 0 to 5 stars)
Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 35.28%

Current $18.85
Target $25.50

Technicals Summary

Sell

Neutral

Buy

Cargo Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cargo Therapeutics
Cargo Therapeutics
36.2%
-41.51%
29.73%
29.73%
29.73%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
5.97%
16.25%
37.11%
69.18%
305.56%
Novo Nordisk A/s
Novo Nordisk A/s
9.99%
-3.52%
34.24%
158.74%
417.73%
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
-5.15%
64.67%
22.72%
31.08%
198.44%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
0.45%
14.0%
36.06%
143.5%
167.72%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cargo Therapeutics
Cargo Therapeutics
NA
NA
NA
-22.47
0.0
0.0
NA
NA
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
29.93
29.93
1.54
45.05
0.17
0.08
NA
261.41
Novo Nordisk A/s
Novo Nordisk A/s
44.01
44.01
1.98
3.44
0.89
0.23
0.01
25.24
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-2.55
-15.01
0.02
NA
-0.02
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
32.84
NA
0.57
0.32
-0.03
0.13
NA
57.26
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cargo Therapeutics
Cargo Therapeutics
Buy
$941.1M
29.73%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$124.7B
305.56%
29.93
32.04%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$585.3B
417.73%
44.01
34.84%
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
Buy
$32.3B
198.44%
NA
-3.11%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$120.9B
167.72%
32.84
-4.74%

Company Information

Organization
Cargo Therapeutics
Employees
150
CEO
Ms. Gina Chapman
Industry
Miscellaneous

FAQs